Subinhibitory concentrations of metronidazole increase biofilm formation in Clostridium difficile strains. 2016

Claudia Vuotto, and Ines Moura, and Fabrizio Barbanti, and Gianfranco Donelli, and Patrizia Spigaglia
Microbial Biofilm Laboratory, IRCCS Fondazione Santa Lucia, 00179 Rome, Italy.

Resistance mechanism to metronidazole is still poorly understood, even if the number of reports on Clostridium difficile strains with reduced susceptibility to this antibiotic is increasing. In this study, we investigated the ability of the C. difficile strains 7032994, 7032985 and 7032989, showing different susceptibility profiles to metronidazole but all belonging to the PCR ribotype 010, to form biofilm in vitro in presence and absence of subinhibitory concentrations of metronidazole. The quantitative biofilm production assay performed in presence of metronidazole revealed a significant increase in biofilm formation in both the susceptible strain 7032994 and the strain 7032985 exhibiting a reduced susceptibility to this antibiotic, while antibiotic pressure did not affect the biofilm-forming ability of the stable-resistant strain 7032989. Moreover, confocal microscopy analysis showed an abundant biofilm matrix production by the strains 7032994 and 7032885, when grown in presence of metronidazole, but not in the stable-resistant one. These results seem to demonstrate that subinhibitory concentrations of metronidazole are able to enhance the in vitro biofilm production of the above-mentioned PCR ribotype 010 C. difficile strains, susceptible or with reduced susceptibility to this antibiotic, suggesting a possible role of biofilm formation in the multifactorial mechanism of metronidazole resistance developed by C. difficile.

UI MeSH Term Description Entries
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001422 Bacterial Adhesion Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity. Adhesion, Bacterial,Adhesions, Bacterial,Bacterial Adhesions
D016360 Clostridioides difficile A common inhabitant of the colon flora in human infants and sometimes in adults. The type species Clostridioides difficile is formerly known as Clostridium difficile. It is a causative agent for CLOSTRIDIOIDES INFECTIONS and is associated with PSEUDOMEMBRANOUS ENTEROCOLITIS in patients receiving antibiotic therapy. Clostridium difficile
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm

Related Publications

Claudia Vuotto, and Ines Moura, and Fabrizio Barbanti, and Gianfranco Donelli, and Patrizia Spigaglia
May 2022, Antibiotics (Basel, Switzerland),
Claudia Vuotto, and Ines Moura, and Fabrizio Barbanti, and Gianfranco Donelli, and Patrizia Spigaglia
May 2023, Journal of fish diseases,
Claudia Vuotto, and Ines Moura, and Fabrizio Barbanti, and Gianfranco Donelli, and Patrizia Spigaglia
January 2013, Gut microbes,
Claudia Vuotto, and Ines Moura, and Fabrizio Barbanti, and Gianfranco Donelli, and Patrizia Spigaglia
October 2023, Pathogens (Basel, Switzerland),
Claudia Vuotto, and Ines Moura, and Fabrizio Barbanti, and Gianfranco Donelli, and Patrizia Spigaglia
February 2015, Antimicrobial agents and chemotherapy,
Claudia Vuotto, and Ines Moura, and Fabrizio Barbanti, and Gianfranco Donelli, and Patrizia Spigaglia
January 2020, PloS one,
Claudia Vuotto, and Ines Moura, and Fabrizio Barbanti, and Gianfranco Donelli, and Patrizia Spigaglia
November 2018, Microbial drug resistance (Larchmont, N.Y.),
Claudia Vuotto, and Ines Moura, and Fabrizio Barbanti, and Gianfranco Donelli, and Patrizia Spigaglia
July 2022, Foods (Basel, Switzerland),
Claudia Vuotto, and Ines Moura, and Fabrizio Barbanti, and Gianfranco Donelli, and Patrizia Spigaglia
August 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Claudia Vuotto, and Ines Moura, and Fabrizio Barbanti, and Gianfranco Donelli, and Patrizia Spigaglia
December 2009, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!